Portfolio Lab

Embecta Corp.

  • Stock
  • Ticker EMBC
  • ISIN US29082K1051
  • Nasdaq

Health care · Medical technology · USA

$6.02 −2.75%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Embecta Corp. since 04/2022, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

EMBCGlobal equities (VT)

$10,000 grew to $3,684. Global equities (VT): $15,235.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −90.6% in 05/2026, measured from the peak in 12/2022. The old peak has not been reached again yet.

1-year return
−54.7%
Return p.a. since 04/2022
−27.3%
Volatility p.a.
62.4%
Largest decline
−90.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end09/202412/202403/202506/202509/202512/202503/202606/2026
Income statement
Revenue286262259296264261222272
Gross profit174157164197159162128153
Operating income2629639457833549
EBITDA36387210370944559
Net income150.024462644-4.121
Earnings per share0.240.000.400.780.440.74-0.070.36
Balance sheet
Total assets1,2851,1501,1201,1571,0911,0641,0291,265
Liabilities2,0241,9181,8561,8271,7421,6771,6551,878
Equity-738-769-736-670-651-613-626-613
Cash268210209231226201185215
Long-term debt1,5651,5351,5091,4591,3891,3531,3171,316
Cash flow
Operating cash flow27-5.3328184173142
Capital expenditure0.0-1.5-0.1-0.4-7.3-0.6-0.5-1.1
Free cash flow27-6.8328177173141

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2024 at +13.5%, weakest 2025 at −39.6%. 1 of 3 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
7 Aug 2026$0.36
5 May 2026−$0.07
5 Feb 2026$0.74
25 Nov 2025$0.44
8 Aug 2025$0.78
9 May 2025$0.40
6 Feb 2025$0.00
11 Dec 2024$0.24
9 Aug 2024$0.25
9 May 2024$0.50
9 Feb 2024$0.35
29 Nov 2023$0.10

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€309m
Market cap in trading currency
$341m
Enterprise value
$1.58bn
P/E
4.1
P/S
0.33
P/B
–
EV/Sales
1.55
EV/EBITDA
5.9
Earnings yield
24.4%
FCF yield
48.3%

Results (last four quarters)

Revenue
$1.02bn
Gross profit
$601m
EBITDA
$268m
Net income
$87.5m
Earnings per share
$1.47
Revenue per share
$17.98
Revenue growth
−8.1%
Earnings growth
−53.6%

Profitability

Gross margin
59.0%
Operating margin
21.9%
Net margin
8.6%
Return on equity
–
Return on assets
6.9%

Balance sheet and cash flow

Cash
$215m
Cash per share
$3.79
Financial debt
$1.46bn
Debt/equity %
–
Current ratio
1.68
Book value per share
−$10.81
Operating cash flow
$174m
Free cash flow
$165m

Dividend

Dividend yield
5.32%
Dividend (12 months)
$0.32
Yield (12 months)
5.32%
Payout ratio
22%
Ex-dividend date
27 Aug 2026

Shares and trading

Shares outstanding
56.7m
Volume
862,789
Avg. volume 3 months
1.04m
Relative volume
0.9

Price and technicals

Price
$6.02
1 day
−2.7%
52-week high
$14.64
52-week low
$2.90
Distance to 52-week high
−58.9%
Distance to 52-week low
+107.6%
Distance to 50-day line
−0.6%
Distance to 200-day line
−0.7%
RSI (14)
44
Volatility 1M
43.4%

Performance

1 week
−6.8%
1 month
−12.2%
3 months
+20.6%
6 months
+81.3%
YTD
−49.3%
1 year
−57.4%

Dates

Fiscal year end
30 Sep 2025
Most recent quarter
30 Jun 2026

Frequently asked questions

How has EMBC performed since 04/2022?

$10,000 grew to $2,282 by 20 Nov 2026, which is −27.3% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is EMBC?

Volatility was 62.4% per year, measured on monthly returns. The largest decline from a peak was −90.6%, with the low in 05/2026.

How does EMBC compare with a broad equity ETF?

Over the same period Global equities (VT) returned +9.5% per year at 15.1% volatility, EMBC returned −27.3% at 62.4%. The correlation of monthly returns was 0.18; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Embecta Corp. (EMBC): Return and risk | Portfolio Lab